Ilika plc (LON:IKA) has recorded contracted commercial revenue from Stereax for the first time, marking what Dr Tom McColm of Morphose Capital Partners describes as a symbolic shift for the solid-state battery developer. In this interview, he explains how sales and potential royalties could develop through Cirtec Medical, why Goliath is attracting greater interest from automotive manufacturers, and how defence, drones and electric bicycles could create earlier routes to revenue.
Key Moments
- 00:17 — Results meet expectations
- 00:30 — First Stereax commercial revenue
- 01:20 — Cash position remains strong
- 02:16 — Stereax revenue begins to scale
- 03:13 — Royalty payments move closer
- 04:02 — Goliath gains automotive interest
- 04:25 — Lower weight, cost and charging time
- 05:26 — New markets open for Goliath
- 05:53 — Defence emerges as an early opportunity
- 07:51 — Key milestones for investors
- 08:46 — Brompton partnership broadens potential
Ilika plc develops solid-state battery technology for specialist and mass-market applications. Its Stereax platform is designed for miniature medical and industrial devices, while its larger-format Goliath programme targets applications including electric vehicles, defence systems, drones and electric bicycles.
